SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-017581
Filing Date
2023-06-15
Accepted
2023-06-15 17:10:24
Documents
13
Period of Report
2023-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbyi20230615_8k.htm   iXBRL 8-K 42679
  Complete submission text file 0001437749-23-017581.txt   175504

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20230613.xsd EX-101.SCH 3601
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20230613_def.xml EX-101.DEF 11532
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20230613_lab.xml EX-101.LAB 15414
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20230613_pre.xml EX-101.PRE 11688
7 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20230615_8k_htm.xml XML 2573
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35703 | Film No.: 231018362
SIC: 2834 Pharmaceutical Preparations